Tag: Aspirin
P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
Reduced risk seen for composite of cardiovascular death, myocardial infarction, and stroke
Increase in Incident Anemia Seen With Low-Dose Aspirin in Older Adults
Risk for anemia incidence and decline in ferritin greater for seniors receiving low-dose aspirin
Higher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
Findings seen in patients with ischemic stroke without occlusion of large or medium-sized vessels, at least one moderately to severely weak limb
Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
Study shows that polygenic score does not modify the 13 percent reduction in ovarian cancer risk seen with aspirin
Aspirin Discontinuation Noninferior for Preventing Preeclampsia
Aspirin discontinuation at 24 to 28 weeks gestation noninferior to continuation until 36 weeks of gestation
Aspirin Noninferior to Low-Molecular-Weight Heparin After Fracture
No significant difference seen in incidence of death, deep vein thrombosis, pulmonary embolism, bleeding complications
Eradicating H. pylori Cuts Aspirin-Related Peptic Ulcer Bleeding in the Short Term
Protection against aspirin-associated peptic ulcer bleeding in older adults lost after the first 2.5 years
Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Stroke patients with normal, but not those with impaired, renal function have greater benefit with ticagrelor-aspirin than clopidogrel-aspirin
Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events
Frequent Aspirin Use Tied to Lower Ovarian Cancer Risk
Association remains regardless of the presence of most other risk factors for ovarian cancer
